These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2966782)

  • 21. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
    de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE
    J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
    Hall H; Högberg T; Halldin C; Köhler C; Ström P; Ross SB; Larsson SA; Farde L
    Psychopharmacology (Berl); 1991; 103(1):6-18. PubMed ID: 1672460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.
    Billings JJ; Guo YZ; Kung MP; Kung HF
    Eur J Nucl Med; 1993 Dec; 20(12):1146-53. PubMed ID: 8299649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
    Chumpradit S; Kung MP; Billings J; Mach R; Kung HF
    J Med Chem; 1993 Jan; 36(2):221-8. PubMed ID: 8093734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T
    Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
    Singhaniyom W; Tsai YF; Brücke T; McLellan CA; Cohen RM; Kung HF; Chiueh CC
    Brain Res; 1988 Jun; 453(1-2):393-6. PubMed ID: 2969766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biodistribution and metabolism of radio-iodinated IBZM in rats].
    Cao G; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):171-3. PubMed ID: 12515126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral kinetics of the dopamine D(2) receptor ligand [(123)I]IBZM in mice.
    Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
    Nucl Med Biol; 2008 May; 35(4):467-73. PubMed ID: 18482684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of D2 dopamine receptors--a basis for semiquantitative measurement of the receptor density using equilibrium analysis].
    Toyama H; Matsumura K; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
    Kaku Igaku; 1994 Sep; 31(9):1117-20. PubMed ID: 7967197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
    Schonwetter BS; Luedtke RR; Kung MP; Billings J; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):110-6. PubMed ID: 2526213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
    Langer O; Halldin C; Dollé F; Swahn CG; Olsson H; Karlsson P; Hall H; Sandell J; Lundkvist C; Vaufrey F; Loc'h C; Crouzel C; Mazière B; Farde L
    Nucl Med Biol; 1999 Jul; 26(5):509-18. PubMed ID: 10473189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple method of preparation for [123I]-(S)-(-)-IBZM.
    Wang TS; Malaspina D; Van Heertum RL
    Appl Radiat Isot; 1998 Apr; 49(4):369-72. PubMed ID: 9519443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease.
    Cordes M; Henkes H; Laudahn D; Bräu H; Kramp W; Girke W; Hierholzer J; Eichstädt H; Felix R
    Eur J Radiol; 1991; 12(3):182-6. PubMed ID: 1830273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
    Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
    Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
    Baldwin RM; Fu X; Kula NS; Baldessarini RJ; Amici L; Innis RB; Tamagnan GD
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4015-7. PubMed ID: 14592497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Brücke T; Podreka I; Angelberger P; Wenger S; Topitz A; Küfferle B; Müller C; Deecke L
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.